Cargando…

Omicron: fewer adverse outcomes come with new dangers

Detalles Bibliográficos
Autores principales:	Post, Lori Ann, Lorenzo-Redondo, Ramon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926409/ https://www.ncbi.nlm.nih.gov/pubmed/35305298 http://dx.doi.org/10.1016/S0140-6736(22)00514-1

Ejemplares similares

Innovations in CKRT: individualized therapy with fewer complications
por: Szamosfalvi, Balazs, et al.
Publicado: (2020)

Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands
por: Dinmohamed, Avinash G, et al.
Publicado: (2020)

Dangerous for ferrets: lethal for humans?
por: Doherty, Peter C, et al.
Publicado: (2012)

Offline: The danger of unreliable narrators
por: Horton, Richard
Publicado: (2021)

Offline: COVID-19 and the dangers of Sinophobia
por: Horton, Richard
Publicado: (2020)

Genomics Comes to Cell Biology
por: Mellman, Ira
Publicado: (2000)

Comment on: COVID-19 patients with obesity at risk for worse outcomes despite younger age and fewer inflammatory derangements
por: Vosburg, R. Wesley
Publicado: (2021)

When science comes before progress
por: Stecher, Benjamin
Publicado: (2019)

Single cell transcriptomics comes of age
por: Aldridge, Sarah, et al.
Publicado: (2020)

The coming of age of the pediatric EBMT criteria
por: Corbacioglu, Selim
Publicado: (2020)

The potential danger of suboptimal antibody responses in COVID-19
por: Iwasaki, Akiko, et al.
Publicado: (2020)

Offline: A dangerous virus, but not the one you think
por: Horton, Richard
Publicado: (2020)

Omicron severity: milder but not mild
por: Nealon, Joshua, et al.
Publicado: (2022)

Coming to Grips With Dangerous Algorithms
por: Mancha, Ruben
Publicado: (2018)

The cell biology of microbial infections: coming of age
por: Galán, Jorge E.
Publicado: (2002)

Africa must come on board the genomics bandwagon
por: Ogundiran, Temidayo O
Publicado: (2005)

COVID-19 and the liver-related deaths to come
por: Pawlotsky, Jean-Michel
Publicado: (2020)

Cancer immunotherapy comes of age and looks for maturity
por: Finck, Amanda, et al.
Publicado: (2020)

New year, new SARS-CoV-2 variant: Resolutions on genomic surveillance protocols to face Omicron
por: Oróstica, Karen Y., et al.
Publicado: (2022)

Omicron in pregnancy: time to breathe easier?
por: Auger, Nathalie, et al.
Publicado: (2022)

Editorial Comment: Larger patients shouldn’t have fewer options: urethroplasty is safe in the obese
por: Favorito, Luciano A.
Publicado: (2020)

Open notes in cancer care: coming soon to patients
por: Blease, Charlotte, et al.
Publicado: (2020)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

Omicron infection milder in nursing home residents
por: Katz, Morgan J, et al.
Publicado: (2022)

Prioritisation of COVID-19 boosters in the omicron era
por: Irving, Stephanie A, et al.
Publicado: (2022)

Artificial intelligence in the medical profession: ready or not, here AI comes
por: Pucchio, Aidan, et al.
Publicado: (2022)

Open questions: genomics and how far we haven’t come
por: Adams, Michael
Publicado: (2013)

Offline: COVID-19—what we can expect to come
por: Horton, Richard
Publicado: (2020)

COVID-19 and the coming epidemic in US immigration detention centres
por: Meyer, Jaimie P, et al.
Publicado: (2020)

Next-generation COVID-19 vaccines: here come the proteins
por: Blakney, Anna K, et al.
Publicado: (2021)

Patient-focused pathogen genetic counselling—has the time come?
por: Ferdinand, Angeline S, et al.
Publicado: (2021)

Microfluidic cell squeeze-based vaccine comes into clinical investigation
por: Wang, Shuhang, et al.
Publicado: (2023)

How Dangerous is Testosterone Supplementation?
por: Jenkins, Lawrence C., et al.
Publicado: (2015)

Milder disease with Omicron: is it the virus or the pre-existing immunity?
por: Sigal, Alex
Publicado: (2022)

Hypertensive and cognitive function: did we come to a dead end?
por: Tadic, Marijana, et al.
Publicado: (2022)

Will the COVID-19 crisis trigger a One Health coming-of-age?
por: de Garine-Wichatitsky, Michel, et al.
Publicado: (2020)

Come take call with me—a plea for action on gun violence
por: Puzio, Thaddeus J.
Publicado: (2023)

Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data
por: De Vito, Andrea, et al.
Publicado: (2023)

Thinking inside the box: intracellular roles for complement system proteins come into focus
por: O’Brien, Rebecca M., et al.
Publicado: (2023)

Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
por: Liew, Jean W, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ule58kt9lagafuq97qjr2vv85i